U.S. Banks Stock News

F5 stock has produced a strong 137.5% gain over the past three years, while current valuation checks suggest investors now face a potential premium to the stock’s intrinsic value estimate. The Discounted Cash Flow (DCF) model points to an overvalued reading, even as market based multiples look closer to in line. Over the past three years, F5 has returned 137.5%, which puts more focus on how much of the company’s cash flow story may already be reflected in the share price. The launch of F5’s...

Navitas Semiconductor has more than doubled over the past year, yet the stock still screens as undervalued on earnings multiples while broader valuation checks suggest it is not an obvious bargain. For investors, the share price strength and the low value score raise the question of how much of the AI power opportunity is already reflected in today’s valuation. Navitas Semiconductor is up 104.3% over the past year, which puts extra focus on whether recent optimism around the business can...

Trade friction between the U.S. and Canada is reshaping how auto parts move across the border, and that can mean sharp winners and losers among domestic components suppliers. With tariffs climbing and supply chains under pressure, investors who understand which stocks are more exposed to this news may find timely openings or risks to avoid. This article walks through three U.S.-listed auto parts stocks that appear particularly exposed to the latest trade headlines. The stocks in this article...

Verizon Communications (VZ) is drawing fresh attention after announcing an expanded partnership with Google Cloud that will roll out Gemini Enterprise AI tools across customer service, network operations, marketing, and internal workflows. Over the past year Verizon Communications has seen momentum build, with a year to date share price return of 24.01% and a 30 day share price return of 8.34%, alongside a 1 year total shareholder return of 22.11%. Recent product launches and upcoming debt...

With Washington openly trying to pull long term borrowing costs lower while the Fed talks tougher on inflation, US housing and homebuilder stocks are suddenly at the crossroads of policy and politics. That mix can reshape mortgage costs, risk appetite and how investors price volatility. This article breaks down how that story connects to home related equities and examines 3 stocks that appear especially exposed to the news. The stocks in the article below are just a starting sample. The full...

Newmont (NEM) is back in focus after a sharp move in the stock following a strong jump in gold prices, as investors weighed lower production, rising costs and reaffirmed full year guidance. At a share price of US$135.14, Newmont has enjoyed a strong run, with a 30 day share price return of 45.02% and a year to date share price return of 33.51%. Total shareholder returns of 88.56% over one year and 265.31% over three years suggest that investors have already been rewarding the stock for...

Planet Fitness (PLNT) is back in focus after multiple law firms reminded investors of upcoming deadlines tied to a securities fraud class action lawsuit, following the company’s disappointing first quarter 2026 update and guidance changes. The class action headlines arrive after a difficult stretch for Planet Fitness shareholders, with the stock closing at $52.54 and the share price down sharply on a year to date basis, while the 1 year total shareholder return has also fallen significantly...

Mercury Systems (MRCY) has drawn investor attention after reporting full year earnings on July 3, 2026, with sales of US$983.62 million and a reduced net loss of US$29.67 million. The Mercury Systems share price has pulled back recently. It has a 7 day share price return of 16.44% and a 30 day share price return of 15.04% from the latest close of US$87.74, while the year to date share price return is 15.40% and the 1 year total shareholder return is 29.72%. Scan how Mercury Systems compares...

Hormel Foods stock has seen a steep share price decline over the past five years, yet the current checks still suggest the shares are not an obvious bargain and may lean expensive on broader valuation measures. The share price is down about 38.1% over five years, which raises questions about how much of the pressure is already reflected in Hormel Foods valuation. The appointment of Ash Bhumbla as chief financial officer may support renewed focus on capital allocation and margins, while...

Tesla (TSLA) has raised prices on several Cybertruck trims while pushing ahead with robotaxi approvals in Nevada and broader software driven services. Together these shifts frame how the stock’s story is evolving. The recent focus on higher margin Cybertruck pricing and robotaxi approvals comes after a mixed year for Tesla’s stock. A 1 month share price gain of 11.89% has partly offset a 20.46% decline over 3 months, while a 3 year total shareholder return of 36.19% still reflects stronger...

Encore Capital Group has delivered very strong share price gains over the past year, yet the valuation checks paint a more mixed picture that stops short of calling the stock either clearly cheap or clearly expensive. The stock has returned 147.7% over the past year, which puts a lot of recent optimism into the current price and raises the bar for further gains. For a debt collection specialist like Encore Capital Group, expectations around how reliably it can turn purchased portfolios into...

In August 2026, Nabors Industries Ltd. filed an omnibus shelf registration, covering guarantees of debt securities, preferred and common shares, warrants, and debt securities of Nabors Industries, Inc. This broad shelf registration gives the company considerable flexibility to raise capital or refinance debt across multiple instruments as conditions evolve. We will now examine how this expanded funding flexibility may influence Nabors Industries' existing investment narrative built around...

Abbott Laboratories (NYSE:ABT) received FDA authorization for its Libre Duo 10 Day system, described as the world's first dual glucose ketone sensing biowearable for diabetes management. The Libre Duo 10 Day device is designed to continuously track both glucose and ketone levels to help address risks linked to diabetic ketoacidosis. Abbott plans a U.S. launch of Libre Duo 10 Day following the FDA authorization, adding a new offering to its digital health and diagnostics portfolio. Investors...

Bronstein, Gewirtz & Grossman, LLC has filed a past class action lawsuit against Pentwater Capital Management LP and CEO Matthew Halbower, alleging deceptive trading practices that artificially inflated Avis Budget Group’s share price via aggressive purchases and a short squeeze, affecting investors between February 20, 2025 and April 21, 2026. This case focuses attention on how trading behavior by a major shareholder, rather than Avis’s operations, may have influenced investor outcomes...

CRISPR Therapeutics previously secured expanded FDA approval for its ex vivo gene-editing therapy Casgevy, extending use to younger sickle cell disease and beta thalassemia patients. This broader label meaningfully enlarges the addressable treatment pool and further validates CRISPR-based therapies in areas with high unmet medical need. We’ll now examine how this expanded FDA approval for Casgevy could reshape CRISPR Therapeutics’ investment narrative and long-term commercial positioning...

Steel Dynamics (STLD) stock is moving after President Donald Trump proposed 50% tariffs on Canadian steel and vehicles starting in 2027. This policy change could reshape competitive pressure for this major US steel producer. At a share price of $231.08, Steel Dynamics has seen short term share price pressure, with the 7 day and 90 day share price returns down 7.5% and 10.5% respectively. However, the year to date share price return of 31.3% and 1 year total shareholder return of 77.5%...

McKesson (NYSE:MCK) announced a deal to acquire Precision Medicine Group to expand its oncology and clinical research services. The transaction is expected to broaden McKesson's role in personalized medicine, clinical trial support, and biopharma commercialization. The acquisition aligns with McKesson's focus on specialty care and could reshape its position across oncology and research services. McKesson is only one example of how large healthcare players are leaning into data driven...

Indivior Pharmaceuticals has delivered a strong 172.0% total return over the past 5 years, yet the stock now screens as undervalued on broader checks after a recent pullback. With a value score in the high range and the share price giving back some ground in recent weeks, investors are weighing whether the market is still underpricing the business. Indivior Pharmaceuticals is up 172.0% over 5 years, which signals that long term holders have already seen substantial gains even before...

Coinbase Global has delivered a very strong 3 year share price gain while the valuation checks lean expensive and recent shorter term returns have been weaker. For investors looking at Coinbase stock today, the key issue is whether that past strength already prices in a lot of optimism. Coinbase Global is up about 121% over the past 3 years, which puts a spotlight on whether the current valuation leaves much room for error. Progress on crypto regulation, such as the proposed CLARITY Act, and...

SentinelOne earnings event puts AI security growth and profitability in focus SentinelOne (S) is approaching its Q2 fiscal 2027 earnings release, with management indicating expected revenue of US$289 million to US$291 million and adjusted earnings of US$0.06 to US$0.08 per share. This update centers on how that upcoming report may reflect momentum in SentinelOne's AI, data, and cloud security offerings, along with the impact of ongoing cost and productivity initiatives on the company’s...

We wouldn't blame Viavi Solutions Inc. ( NASDAQ:VIAV ) shareholders if they were a little worried about the fact that...

ABM Industries stock has delivered a 9.2% total return over the past 3 years, yet recent short term softness and a high value score suggest the shares may lean cheap rather than stretched at around US$46.59. The 9.2% return over 3 years points to steady but unspectacular shareholder gains that do not obviously signal a euphoric pricing of ABM Industries. Expectations for dependable facility services demand can support earnings resilience. At the same time, any sustained pressure on labor...

Aflac (AFL) has drawn fresh investor attention after recent trading left the stock about 7.5% lower over the past month, even as its past 3 months and 1 year total returns remain positive. At the current share price of $116.18, Aflac’s recent 7 day and 1 month share price returns, both in decline, mark a pullback against a still positive year to date share price return and a multiyear total shareholder return that has remained strongly positive. Look beyond Aflac’s pullback and compare this...

In August 2026, Progress Software released a major update to its Telerik and Kendo UI product lines, embedding context-aware AI into UI generation, debugging, accessibility, legacy app modernization and RAG-powered data interaction for .NET developers. The same week, the company appointed veteran technology leader Bridget Collins as CIO to drive internal AI adoption and cybersecurity, aligning Progress Software’s own operations with the AI-first development capabilities it now offers...